Hamostaseologie

Article	Citations
Veranstaltung des BDDH am 03.03.2022 im Rahmen der 66. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) in Leipzig	63
Gründung des Fachausschusses für das Deutsche Hämophilieregister (DHR) und Medizinische Informationsobjekte (MIO)	35
Medizinforschungsgesetz, Apothekenreform-Gesetz, Telemedizin Blutspende-Verordnung, Erweiterung der Dokumentationspflichten im Deutschen Hämophilieregister (DHR)	18
GTH 2025 ARTE: The Art in Science – Curiosity and Creativity	18
Current Topics from the Revised German S2k Guideline on Diagnosis and Treatment of Venous Thromboembolism	18
Übergewicht und Adipositas erhöht Risiko für venöse Thromboembolien	17
	16
A novel assay to quantify extrinsic tenase complexes in body fluids	13
Asundexian and milvexian: Pharmacodynamic insights from coagulation assays	13
Erratum: Aktueller Bericht der BDDH über die aktuellen gesundheitspolitischen Entwicklungen mit politischer Einordnung	13
Platelet activating histone/anti-histone immune complexes are associated with a new entity of thrombosis and thrombocytopenia syndrome	12
Tolerance Breakdown in Hemophilia A Mice is Orchestrated by Bacterial Infection Modulating Antigen-Specific B and T cell Responses	12
ITAM upregulation in platelets after major surgery	12
Current Concepts of Pathogenesis and Treatment of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms	11
	11
Hemophilia care from pediatrics to adulthood – a model of joint interdisciplinary guided transition at a Hemophilia Comprehensive Care Center (HCCC)	11
Assessing the impact of a pulmonary embolism response team on patients presenting with intermediate risk acute pulmonary embolism. A prospective study (ongoing)	10
Long-term management of deep vein thrombosis based on medical history - A prospective cohort analysis	9
Elevated von Willebrand factor levels during anticoagulation predict early recurrence of venous thromboembolism	8
Gabapentin and pregabalin can be associated with clinically relevant bleeding due to disturbed platelet function – Two case reports	8
Subsegmental Pulmonary Embolism	7
Immune Thrombocytopenia: Characteristics of the Population and Treatment Methods—One-Center Experience	7
Die Gesellschaft für Thrombose- und Hämostaseforschung e.V. informiert	7
Komplementdysregulation als Biomarker für Post Covid	7
Platelets in Myocardial Ischemia/Reperfusion Injury	7

The Current Evidence of Pulmonary Embolism Response Teams and Their Role in Future	7
High Prevalence of Plasminogen Activator Inhibitor-1 4G/5G Polymorphism among Patients with Venous Thromboembolism in Kerala, India	7
Blutspende auch ohne Arztanwesenheit und aktueller Stand des Apothekenreform-Gesetzes (ApoRG)	6
Differential platelet activation and thrombo-inflammatory mechanisms in early onset and late onset preeclampsia	6
A Vicious Circle of Clonal Haematopoiesis of Indeterminate Potential and Cardiovascular Disease	6
Management of Hemophilia C (Factor XI Deficiency) in Two Families: A Case Study at the University Hospital of Halle (Saale)	6
Reference Intervals in Coagulation Analysis	6
Autoantibody-induced platelet Fc-gamma-RIIA-mediated procoagulant platelets are important drivers of immunothrombosis in antiphospholipid syndrome	6
Splanchnic Vein Thrombosis: The State-of-the-Art on Anticoagulant Treatment	6
Results of an international survey (ISTH) on the management of therapeutic-intensity unfractionated heparin	5
Targeting antigen-specific B cells in immune mediated thrombotic thrombocytopenic purpura using modular CAR T cells	5
Pregnancy complications in female haemophilia patients and carriers of haemophilia A and B- a nationwide survey	5
Increased transfusion requirement in children compared to adults undergoing cardiac surgery	5
Efficacy of Rivaroxaban in Children with Short Bowel Syndrome	5
Bleeding Disorder of Unknown Cause: A Diagnosis of Exclusion	4
GTH News	4
Cardiac and Cerebral Arterial Complications of Lemierre Syndrome: Results from a Systematic Review and Individual Patient Data Meta-analysis	4
Thrombocytopenia Absent Radius (TAR)-Syndrome: From Current Genetics to Patient Self-Empowerment	4
Venous Thromboembolism in Women with Cancer with an Additional Focus on Breast and Gynecological Cancers	4
Correlation between Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio and Burden of Thrombus with Disease Severity in Patients with Pulmonary Thromboembolism	4
Enhanced platelet turnover after acute myocardial infarction in thrombocytopenic mice and GPVI-deficient mice	4
Management of Antithrombin Deficiency in Pregnancy	4
Runder Tisch zum deutschen Hämophilieregister (DHR), drohender Praxenkollaps, Stand und Zukunft der ambulanten hämostaseologischen Versorgung in Deutschland	4
Erratum: A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited Dysfibrinogenemia	4
Familial Protein S deficiency with severe venous thromboembolism (VTE)	3
	3
Bleeding Risk in Patients with Cancer	3
Nonfactor Therapies: New Approaches to Prophylactic Treatment of Haemophilia	3
Update des Versorgungsvertrages nach § 132 i SGBV	3
Neuigkeiten zur Ablösung der geplanten Ablösung der In-Vitro-Diagnostika-Richtlinie durch die In-Vitro-Diagnostika-Verordnung (IVDR) 05/2022 und Plasmaversorgung in Deutschland/EU und Fortführung der	3
Influence of coagulation proteases on cognitive function	3
Venous Thrombosis and SARS-CoV-2	3
Development and evaluation of a novel machine learning algorithm for outpatient thrombophilia diagnosis, management, and venous thrombosis risk stratification	3
Diagnosis of Platelet Function Disorders: A Challenge for Laboratories	3
Changes in Hemophilia Treatment in the Eastern Part of Germany between 2015 and 2021—Data from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)	3
Gleiches Risiko für schwere kardiovaskuläre Ereignisse nach hämorrhagischem und ischämischem Schlaganfall	3
GTH News	3
Inhibition of MicroRNA-122-5p Relieves Myocardial Ischemia-Reperfusion Injury via SOCS1	3
Petition „Vergütung für medizinische Leistungen – Verbesserung der Rahmenbedingungen für die ambulante Versorgung“, ATMP-QS-Richtlinie Hämophilie und aktueller Stand zur Digitalisierung im Gesundheits	3
The Impact of non-factor VIII therapy in haemophilia A on procoagulant platelets	3
Recognizing inherited platelet disorders on the peripheral blood smear by immunofluorescence microscopy: results of the first international workshop	3
Veranstaltung des BDDH im Rahmen der 67. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung in Frankfurt	3
The Use of Large Animal Models in Trauma and Bleeding Studies	3
Communication in Healthcare: Global challenges in the 21st Century	3
Acquired von Willebrand Syndrome in Children	3
Experiences in Routine Genetic Analysis of Hereditary Hemorrhagic, Thrombotic, and Platelet Disorders	3
Platelets and COVID-19	3
Hypofibrinolytic dysregulations can be detected of frozen plasma samples using viscoelastic testing	3
Geringe α-Thrombin/GPIbα-Interaktion trägt möglicherweise zur Hyperreaktivität der Thrombozyten bei COVID-19-Patienten bei	2
	2

Determination of thrombotic risk in patients with antiphospholipid syndrome using a modified thrombin generation assay	2
Venous Thromboembolism Issues in Women	2
Treatment of Atypical Clots	2
Role of Tissue Transglutaminase 2 in Fibrin Formation and Haemostasis	2
Endothelial Mechanisms Modulate the Prothrombotic Phenotype of Factor V Leiden Carriers: Evidence from an Ex Vivo Model	2
Haemostaseological pearls	2
GTH News	2
Identification of novel cryptic epitopes uncovers a distinct and consistent open ADAMTS13 conformation in iTTP	2
In Japan 40% Blutungskomplikationen während ECMO-Therapie bei COVID-19	2
Transfusion älterer Erythrozyten erhöht Mortalität und Thromboembolie-Risiko	2
Treatment of Inherited Platelet Disorders: Current Status and Future Options	2
A Review of FXIa Inhibition as a Novel Target for Anticoagulation	2
Investigating the impact of oligogenic variation on severity of bleeding in hypofibrinogenemia	2
Erratum: Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH	2
Integration of Extracorporeal Membrane Oxygenation into the Management of High-Risk Pulmonary Embolism: An Overview of Current Evidence	2
A patient with Klippel-Trénaunay-Syndrom and cerebral venous sinus thrombosis	2
Guidance-Based Appropriateness of Hemostasis Testing in the Acute Setting	1
Intensive lifestyle intervention on thrombin generation in individuals at high risk for type 2 diabetes	1
Reform des Kapitels 32 (Laboratoriumsmedizin) im einheitlichen Bewertungsmaßstab (EBM)	1
Microvascular Skin Manifestations Caused by COVID-19	1
	1
Fine-Tuning of Platelet Responses by Serine/Threonine Protein Kinases and Phosphatases—Just the Beginning	1
Noncanonical Regulation of ACKR3/CXCR7 on Lipid Mediators in Immunothrombotic Platelet Response following FcγRIIa Stimulation	1
Managing immune thrombocytopenia (ITP) during pregnancy- Single centre 15 years experience at a tertiary care institute	1
Fibrinogen Bonn (p. Arg510Cys) in the Aα-Chain Is Associated with High Risk of Venous Thrombosis	1
Platelet Dysregulation in the Pathobiology of COVID-19	1
GTH News	1
Marker der Akute-Phase-Reaktion könnten Blutungen bei Hämophilie detektieren	1
Fibrin exposition on the surface of the remaining part of arterial thrombus arrests the thrombus growth	1
Stable Factor IX Expression and Sustained Reductions in Factor IX Use 8 Years After Gene Therapy With CSL220 (Formerly AMT-060) in Adults with Hemophilia B [ENCORE]	1
Genetic Analysis of Hereditary Coagulation Factor V Deficiency in Two Chinese Families Caused by Compound Heterozygous Mutations	1
Glycoprotein-specific antibodies modulates platelet phenotypes in an epitope-dependent manner	1
Effectiveness of emicizumab under real-world conditions in patients of all ages with hemophilia A with and without FVIII inhibitors: Third interim analysis of the non-interventional study EMIIL	1
NBEAL2 related Gray Platelet Syndrome with a combined platelet granules secretion defect in flow cytometry	1
Clot-Wave-Analyse könnte individualisierte Therapie bei Hämophilie A verbessern	1
Animal and Cellular Models in Thrombosis and Hemostasis	1
Chronic Venous Disease: Pathophysiological Aspects, Risk Factors, and Diagnosis	1
Promoting young talents - “Coagulation for bloody beginners” („Gerinnung für blutige Anfänger*innen“)	1
Feasibility of a VWF:Ag latex immunoassay on a fully automated coagulation analyzer	1
Successful Secondary Endovascular Intervention in Pediatric Patients with Venous Thromboembolic Events	1
Treatment Burden during a Phase 3 Randomized, Crossover Study of Recombinant ADAMTS13 Prophylaxis and Standard of Care in Patients with Congenital Thrombotic Thrombocytopenic Purpura	1
Cardio-Oncology: A New Discipline in Medicine and Its Relevance to Hematology	1
The evidence of enlarged platelets with reduced expression of glycoprotein Ib/IX might indicate recessive inherited thrombocytopenias other than Bernard-Soulier Syndrome	1
Residuale Venenokklusion nach längerer Antikoagulanzien-Therapie nicht mit erneuten venösen Thromboembolien assoziiert	1
The Great Return: Rebuilding and Advancing the Swiss Haemophilia Registry	1
Primary Prevention of Cancer-Associated Thrombosis: Current Perspectives	1
The Potential of HMB-001 as a Prophylactic Treatment of Glanzmann Thrombasthenia: Interim Analysis of the Phase 2 Study	1
Post Partum Haemorrhage: prepartum plasmin and thrombin generation is similar in women with and without PPH	1
From Code to Clots: Applying Machine Learning to Clinical Aspects of Venous Thromboembolism Prevention, Diagnosis, and Management	1
Intravital Imaging of Thrombosis Models in Mice	1
Digenic Inheritance of PROC and SERPINC1 Mutations Contributes to Multiple Sites Venous Thrombosis	1
Novel Perspectives on Thrombopoietin Receptor Agonists Applications	1
Evaluating the prevalence and profile of antibodies against Polyethylene Glycol in hemophilia patients and healthy Individuals	1
Progress in Hemostasis (Part 1): Improved Management of Inherited Platelet Disorders: Reality or Illusion?	1
Advancing Treatment Options: Two Phase 3 Studies Investigating the Efficacy, Safety, and Pharmacokinetics of an Antithrombin Concentrate in Patients with Congenital and Acquired Antithrombin Deficienc	1
First Interim Analysis of Clinical Outcomes in Adults and Adolescents With Severe Hemophilia A Receiving Efanesoctocog Alfa Prophylaxis in XTEND-ed, a Phase 3 Long-term Extension Study	1
Use of Vonicog Alpha and Acquired von Willebrand Syndrome, a New Approach: A Case Report	1
vWF/GPIb mechano-dependent interactions require F-actin disassembly by the oxidoreductase MICAL1	1
Recurrent Venous Thromboembolism in Patients on Anticoagulation: An Update Based on the Revised AWMF S2k Guideline	1
Recombinant factor VIII binding to platelets influences fibrin clot formation and stability	1
Quantifying Residual Rivaroxaban Plasma Concentration after Antagonization with Andexanet Alfa: A Difficult Task in Routine Clinical Practice	1
Molecular Genetics of Fletcher and Fitzgerald Traits	0
In-vitro Evaluation of Anti-PEG Antibody Effects on the Activation of PEGylated Therapeutic FVIII and FIX Products	0
Tackling the implementation hurdle: User-centric validation of a machine-learning decision support tool for the screening of mild bleeding disorders	0
Clinical and Functional Assessment of Elderly Patients with Haemophilia	0
Efficacy and safety of valoctocogene roxaparvovec 4 years after gene transfer in GENEr8-1	0
	0
Challenging Situations in the Treatment of Cancer-Associated Thrombosis	0
Procoagulant Platelets as a Compensatory Mechanism and Their Impact on Bleeding Severity in Hemophilia A	0
Natural history of isolated distal deep vein thrombosis without anticoagulation. Prospective cohort under ultrasound surveillance	0
Severe autoimmune Heparin Induced Thrombocytopenia with persistence over years: a case report	0
Thrombozyten: Blutstillung ohne Gerinnselbildung	0
Priv.-Doz. Dr. med. Rainer B. Zotz	0
Marcumar-Intoxication: The Perils of Near-Homonyms	0
Sustained Efficacy of Marstacimab in Adults and Adolescents with Severe Hemophilia A or B without Inhibitors	0
	0
Update on the Use of Thrombopoietin-Receptor Agonists in Pediatrics	0
Increasing Use of Anticoagulants in Germany and Its Impact on Hospitalization for Tooth Extraction	0
Management of Recurrent Venous Thromboembolism in Severe Immune Thrombocytopenia: A Case Report and a Review of the Literature	0
GTH News	0

Assessment of plasma levels of D-dimer and prothrombin fragment 1+2 in patients on direct oral anticoagulants versus vitamin K antagonists	0
Erratum: Effect of DDAVP on Platelet Activation and Platelet-Derived Microparticle Generation	0
COVID-19: Cardio-pulmonary and Vascular Manifestations	0
Update on Cancer-Associated Venous Thromboembolism in Children	0
Direct Oral Anticoagulants for Pulmonary Embolism	0
Sequential combinations of rapid immunoassays for prompt recognition of heparin-induced thrombocytopenia: a prospective validation study	0
100 Years of Thrombotic Thrombocytopenic Purpura: A Story of Death and Life	0
Specific reversal of factor Xa inhibitors with single domain antibodies	0
	0
Hemostasis modification in the presence of concizumab combined with donors' platelets, rFVIIa and/or tranexamic acid assessed by modified rotational thromboelastometry in patients with Glanzm	0
Mim8 Prophylaxis Beyond Bleeding: Investigating Multifaceted, Patient-reported Outcomes for Hemophilia A in the FRONTIER2 Study	0
Venous thromboembolism therapy with edoxaban in daily - care patients: results from the DRESDEN NOAC REGISTRY	0
Caplacizumab Added to Plasma Exchange and Immunosuppression Accelerates Recovery and Improves Survival in Immune-Mediated TTP: an International Real-World Study of the IWG-TTP (The Capla 1000+Project)	0
VTE Risk Assessment and Prevention in Pregnancy	0
Thrombozytopenie: Sind Thrombozytentransfusionen vor Legen eines ZVK verzichtbar?	0
Thrombotic Ghost as a Complication of Anticoagulation Therapy: The Challenge of Anticoagulating Intracardiac Thrombi in Patients with Factor VII Deficiency	0
Whole exome siquensing pannel for inbor errors of immunity - findings in a cohort of children with chronic immune thrombocytopenia	0
Nachruf auf Rainer B. Zotz und Ankündigung der BDDH-Veranstaltung auf der GTH in Frankfurt 2023	0
	0
Double CRISPR/Cas9-knockout of ER chaperones, ERGIC transporters and GABARAPs reveal additive and dominant effect on FVIII secretion	0
Detection of joint bleeding symptoms in Haemophilia with the Noraxon system – pilot study	0
Expression and Release of Tumor Cell Tissue Factor Triggers Recurrent Thromboembolism in a Patient with Endometrial Cancer	0
Pitfalls in Coagulation Testing	0
Perioperative Management with Efanesoctocog Alfa in Adults, Adolescents, and Children with Severe Hemophilia A in the Phase 3 XTEND Clinical Program	0
Health-related quality-of-life outcomes 4 years after treatment with valoctocogene roxaparvovec	0
Anti-Thrombin IgA in a Patient with Multiple Myeloma Leading to In Vitro Interference in Multiple Coagulation Tests and Confounding Diagnosis	0
	0
	0
Cancer-Associated Venous Thromboembolism—Diagnostic and Therapeutic Considerations: An Update Based on the Revised AWMF S2k Guideline	0
A Novel Rapid Clotting Assay for Tissue Factor Pathway inhibitor (TFPI)	0
The Use of DOACs in Pediatrics: Current Therapeutic and Prophylactic Indications, Cardiac Indications, and Real-World Evidence—A Review	0
Im letzten Augenblick verhindert: Geplante Übertragung der Richtlinienbefugnis bezüglich Herstellung und Anwendung von Blut und Blutprodukten von der Bundesärztekammer (BÄK) auf das Paul-Ehrlich-Insti	0
Women and Hereditary Bleeding Disorders	0
FXIa-Triggered Thrombin Generation to Predict Breakthrough Bleeding in Acquired Hemophilia A: Data from the GTH-AHA-EMI Study	0
Antithrombotic Treatment for Left Ventricular Assist Devices: One Does Not Fit All	0
Global Coagulation Testing in Acute Care Medicine: Back to Bedside?	0
Non–Vitamin K Antagonist Oral Anticoagulants in Coronary Artery Disease	0
PAS: Die Rolle von Natriumcitrat bei längerer Kaltlagerung von Thrombozyten	0
Probleme der Digitalisierung sowie Protest gegen das Finanzstabilisierungsgesetz	0
Development of an innovative approach based on targeted anticoagulation for the treatment of VTE	0
Association of Thrombin-Activatable Fibrinolysis Inhibitor with Acute Pulmonary Embolism	0
A reinforced fibrin- and platelet-rich layer on the exterior surface of hemostatic blood clots in vivo is formed by platelet contraction	0
COVID-19: SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia	0
Novel Likely Pathogenic Variant in the A3 Domain of von Willebrand Factor Leading to a Collagen-Binding Defect	0
Etranacogene dezaparvovec hemophilia B gene therapy phase 2b trial final results: stable and durable FIX level expression over 5 years [ENCORE]	0
Plasma factors might interfere with platelet function in patients with decompensated liver cirrhosis	0
Extensive Thromboembolism in a Young Male with Asymptomatic COVID-19 Infection and Heterozygous Factor V Leiden Mutation	0
Compassionate use of osocimab in preventing thrombotic complications without incremental bleeding: a case report	0
Efficacy and safety of Mim8 prophylaxis in adults and adolescents with hemophilia A with or without inhibitors: Phase 3, open-label, randomized, controlled FRONTIER2 study	0
Pulmonary Hypertension and COVID-19	0
GPVI-mediated platelet activation aggravates inflammation and progressive aortic wall remodelling in abdominal aortic aneurysm formation	0
Unravelling the Role of Coagulation Factors in Hemophilia A-Associated Bone Metabolism	0
New Anticoagulants in Neonates, Children, and Adolescents	0
Evidence-Based Medicine: Principles and Values as Illustrated by the Case of Patient Blood Management	0
VITT-like anti-PF4 antibodies need to be considered in patients with thrombocytopenia and thrombosis	0
Type 2B von Willebrand Disease: Early Manifestation as Neonatal Thrombocytopenia	0
Grundlagen zur Anwendung von Andexanet	0
Applicability of and adherence to anticoagulation-related standard-operating-procedures in standard surgical procedures – a single center quality control experience	0
Real-world use of rIX-FP in people with haemophilia B: Final results from a prospective, non-interventional study in Germany	0
Joint health and physical activity in people with haemophilia A without factor VIII inhibitors before switching to emicizumab prophylaxis: Beyond ABR study interim analysis	0
Platelets and Sera from Donors of Convalescent Plasma after Mild COVID-19 Show No Procoagulant Phenotype	0
	0
Platelet desialylation is mediated by upregulated plasmatic neuraminidase activity and linked to platelet dysfunction in sepsis	0
Anticoagulation Therapy in Cancer Patients with Thrombosis in the Outpatient Sector of Germany (The CERTIFICAT Initiative)—German Practice of Anticoagulation Therapy of Cancer Patients with Thrombosis	0
Perioperative Management for Port Catheter Procedures in Pediatric Patients with Severe Hemophilia and Inhibitors	0
Die Gesellschaft für Thrombose- und Hämostaseforschung e.V. informiert	0
Impact of Tyrosine Kinase Inhibitors Applied for First-Line Chronic Myeloid Leukemia Treatment on Platelet Function in Whole Blood of Healthy Volunteers In Vitro	0
Pulmonary Embolism: Don't Start Me to Talkin'	0
A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited Dysfibrinogenemia	0
Diagnosis and Therapy of Visceral Vein Thrombosis: An Update Based on the Revised AWMF S2k Guideline	0
Pathophysiology of Trauma-Induced Coagulopathy	0
Utility of Global Hemostatic Assays in Patients with Bleeding Disorders of Unknown Cause	0
Flow Chamber Analyses in Cardiovascular Research: Impact of Platelets and the Intercellular Crosstalk with Endothelial Cells, Leukocytes, and Red Blood Cells	0
Type 2 Diabetes: Platelets and Long-Term Metabolic Control as Estimated from Glycosylated Haemoglobin (HbA1c)	0
Hemostaseology in Pediatrics	0
Von Willebrand Disease—Specific Aspects in Women	0
Platelet Reduction in Rats Exposed to Chronic Hypoxia Is Associated with Interaction of Glycoprotein Ib Alpha von Willebrand Factor	0
Fachgespräche zur Plasma-Versorgung in Deutschland und Sachstand zur neuen Gebührenordnung für Ärzte (GOÄ)	0
Combining Diagnostics and Research in an Academic Laboratory	0
	0
TFPI deletion in myeloid cells exacerbates atherosclerotic plaque development	0
Comparison of Performances among Four Bleeding-Prediction Scores in Elderly Cancer Patients with Venous Thromboembolism	0
Controlling Patient Multiple Electrode Aggregometry Results with Blood Samples of Blood Donors Improves Clinical Interpretation	0
Update on Thrombosis Risk in Patients with Cancer: Focus on Novel Anticancer Immunotherapies	0
Thiol isomerase inhibition with bacitracin or rutin interferes with tissue factor production in myelomonocytic HL-60 cells and isolated AML blasts	0
Aspects of long-term joint health in haemophilia A: inSight Joint Health tool	0
A Cross-sectional Analysis of Treatment in PUPs in 2021 in Germany – First Data from the GEPHARD Study Group	0
Switching factor VIII treatment in pediatric hemophilia A patients: Efficacy and Safety of Efanesoctocog Alfa	0
Paving the way to assay automation: Improving and simplifying VWF activity determination of VWF concentrates	0
Post–Pulmonary Embolism Syndrome: An Update Based on the Revised AWMF-S2k Guideline	0
Epithelial thrombin-PAR1 signaling and Nippostrongylus brasiliensis infection drive small intestinal villus vascularization	0
Effects of radiosynoviorthesis on pain in patients with haemophilia	0
Antithrombotic Therapy in Cancer Patients with Cardiovascular Diseases: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) a	0
	0
Analysis of the platelet activation profile in a novel experimental mouse model of AAA formation and progression	0